More robust analytical evidence should support the selection of human chorionic gonadotropin assays for oncology application.

Ferraro, Simona

More robust analytical evidence should support the selection of human chorionic gonadotropin assays for oncology application. [electronic resource] - Clinical chemistry and laboratory medicine 02 2020 - e61-e63 p. digital

Publication Type: Letter; Comment

1437-4331

10.1515/cclm-2019-0973 doi


Biological Assay
Biomarkers, Tumor
Chorionic Gonadotropin
Chorionic Gonadotropin, beta Subunit, Human
Humans